Cleantech Building Materials: Loan Facility Debt Conversion, Exercise of Options and Issue of New Shares

Udgivet den 08-04-2020  |  kl. 14:07  |  

8 April 2020

CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN

TICKER:  CBM
ISIN:  GBOOBVIVRR47

CLEANTECH BUILDING MATERIALS PLC

LOAN FACILITY DEBT CONVERSION, EXERCISE OF OPTIONS AND ISSUE OF NEW SHARES

Cleantech Building Materials PLC ("CBM" or the "Company") announces that the Company has reached an agreement with its loan provider, as disclosed in the CBM Company Description published on 20 December 2016, to convert €436,489.04 of outstanding debt into 1,047,574 new ordinary shares of £0.10 each in the Company ("Ordinary Shares"), and, in accordance with the provisions of the loan agreement, for the new Ordinary Shares to be issued to a number of parties (the "Conversion"). No such party will hold 5% or more of the Company's issued share capital. The Company will apply for the 1,047,574 new Ordinary Shares to be admitted to trading on the Exchange.

Separately the Company is pleased to announce that it has received notice of exercise of share options from option holders as also disclosed in the CBM Company Description published on 20 December 2016, and accordingly 1,021,850 new Ordinary Shares at a price of €0.35 each will be issued to the option holders (the "Option Issue"). The Company will apply for the 1,021,850 new Ordinary Shares to be admitted to trading on the Exchange.

Following the Conversion and the Option Issue, the issued share capital of the Company will be 68,366,160 Ordinary Shares, with no Ordinary Shares held in Treasury. Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to, their interest in Ordinary Shares under the Disclosure Guidance and Transparency Rules.

THE DIRECTORS OF CLEANTECH BUILDING MATERIALS PLC ACCEPT RESPONSIBILITY FOR THE CONTENTS OF THIS ANNOUNCEMENT

Further information may be found at the Company's website at www.cbm-plc.com

Further Enquiries:

Cleantech Building Materials plc
Adrian Wyn-Griffiths
info@cbm-plc.com
+44 20 3934 6630

 

 
Keswick Global AG (Certified Adviser) info@keswickglobal.com 
+43 1 740 408045

 

 
IFC Advisory Limited (Financial PR)
Tim Metcalfe
Zach Cohen
+44 20 3934 6630

The information communicated in this announcement is "inside information" for the purposes of article 7 of the Market Abuse Regulation 596/2014.

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

06:30 Kalender med link - mandag den 18. november
17:46 Europa/lukning: RFK som USA's sundhedsminister var gift for medicinalaktierne
17:07 Fredagens aktier: Nedtur til medicinalaktierne trak C25 i laveste niveau i år
17:00 Fredagens obligationer: Renten hoppede på stedet trods stærke tal fra USA
15:52 Forventninger dæmpes: Nu kun "fifty-fifty" om Fed sænker renten i december
15:39 USA/åbning: Kommentar fra Powell om renteudsigterne presser aktierne
15:08 Tørlastindekset Baltic Dry stiger for ottende gang på ni dage
14:00 USA/tendens: Powells rolige rentetilgang sender futures i rødt
13:55 DFDS-aktien i vejret efter alligevel at være kommet i mål med tyrkisk opkøb
13:16 Europa/aktier: Valg af vaccineskeptiker som USA's sundhedsminister tynger medicinal
13:14 DFDS køber alligevel tyrkisk virksomhed men på nye betingelser
13:07 SP Groups markante indtjeningsfremgang drevet af øget salg af egne varemærker
12:55 Trumps udnævnelse af kontroversiel sundhedsminister lægger pres på danske medicinalaktier
12:01 Obligationer/middag: Renten går et nøk ned inden amerikansk detailsalg
11:54 Aktier/middag: Bavarian får klø efter regnskab og kontroversielt ministervalg i USA
11:24 Efter en periode på sidelinjen anbefaler Danske Bank igen køb af NKT-aktien
11:12 Vi har rykket en del af julegaveindkøbene til andet kvartal siger MAtas-topchef
10:34 Bavarian Nordic løfter lidt af sløret for 2025: Har hentet ordrer for 2,4 mia. kr.
10:07 Topchef i Matas om omsætningsvækst: Flere nye varer, striber i Norden og hurtig levering
09:22 Bavarian dykker på bekymringer om 2025 og USA's nye sundhedsminister